| 2026-08-05 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-08-05 | Bestätigt | Barclays | Equal Weight |
| 2026-08-05 | Bestätigt | Citigroup | Neutral |
| 2026-08-05 | Bestätigt | Evercore ISI | In-line |
| 2026-08-05 | Bestätigt | Guggenheim | Buy |
| 2026-08-05 | Bestätigt | Mizuho | Outperform |
| 2026-08-05 | Bestätigt | Morgan Stanley | Overweight |
| 2026-08-05 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2026-08-05 | Bestätigt | Robert W. Baird | Neutral |
| 2026-08-05 | Bestätigt | UBS | Buy |
| 2026-07-16 | Resumed | Wedbush | Neutral |
| 2026-07-08 | Eingeleitet | DA Davidson | Buy |
| 2026-04-27 | Herabstufung | Rothschild & Co Redburn | Buy → Neutral |
| 2026-04-07 | Resumed | Wells Fargo | Overweight |
| 2026-03-02 | Herabstufung | Argus | Buy → Hold |
| 2026-02-13 | Herabstufung | BofA Securities | Buy → Neutral |
| 2026-02-13 | Herabstufung | Citigroup | Buy → Neutral |
| 2026-02-13 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2026-02-13 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-02-13 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-02-13 | Herabstufung | Loop Capital | Buy → Hold |
| 2026-02-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-01-30 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-12-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2025-11-05 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2025-11-05 | Herabstufung | Rosenblatt | Buy → Neutral |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-08-08 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-21 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-06-03 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-05-15 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-05-09 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-05-09 | Bestätigt | Barclays | Equal Weight |
| 2025-05-09 | Bestätigt | Citigroup | Buy |
| 2025-05-09 | Bestätigt | Guggenheim | Buy |
| 2025-05-09 | Bestätigt | JP Morgan | Neutral |
| 2025-05-09 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-09 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-09 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-09 | Bestätigt | Seaport Research Partners | Buy |
| 2025-05-09 | Bestätigt | Wedbush | Outperform |
| 2025-04-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-03-24 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-02-07 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-02-07 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-13 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-10 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2024-12-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-26 | Eingeleitet | TD Cowen | Buy |
| 2024-11-11 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-09-24 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-23 | Eingeleitet | Deutsche Bank | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-31 | Bestätigt | Barclays | Equal Weight |
| 2024-07-31 | Bestätigt | Citigroup | Buy |
| 2024-07-31 | Bestätigt | JP Morgan | Neutral |
| 2024-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-07-31 | Bestätigt | Piper Sandler | Overweight |
| 2024-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-16 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-01-18 | Hochstufung | Argus | Hold → Buy |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-12-20 | Resumed | Raymond James | Outperform |
| 2023-12-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-30 | Hochstufung | Jefferies | Hold → Buy |
| 2023-11-27 | Eingeleitet | New Street | Buy |
| 2023-10-31 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-10-23 | Hochstufung | Stifel | Hold → Buy |
| 2023-10-18 | Eingeleitet | Jefferies | Hold |
| 2023-09-26 | Eingeleitet | Jefferies | Buy |
| 2023-09-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-09-20 | Hochstufung | DA Davidson | Neutral → Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Neutral |
| 2023-08-02 | Hochstufung | Rosenblatt | Neutral → Buy |
| 2023-07-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-07-17 | Bestätigt | Credit Suisse | Neutral |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-06-28 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-04-28 | Bestätigt | Bernstein | Mkt Perform |
| 2023-04-28 | Bestätigt | Credit Suisse | Neutral |
| 2023-04-28 | Bestätigt | JP Morgan | Neutral |
| 2023-04-28 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-28 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2023-04-28 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-28 | Bestätigt | Rosenblatt | Neutral |
| 2023-04-28 | Bestätigt | UBS | Buy |
| 2023-04-20 | Bestätigt | Bernstein | Mkt Perform |
| 2023-04-06 | Eingeleitet | Raymond James | Outperform |
| 2023-03-27 | Hochstufung | UBS | Neutral → Buy |
| 2023-01-20 | Herabstufung | MKM Partners | Buy → Neutral |
| 2022-12-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-10-06 | Hochstufung | Goldman | Neutral → Buy |
| 2022-09-07 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2022-08-02 | Hochstufung | Susquehanna | Neutral → Positive |
| 2022-06-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Resumed | Citigroup | Neutral |
| 2022-04-19 | Eingeleitet | Rosenblatt | Neutral |
| 2022-03-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-17 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-03-01 | Eingeleitet | The Benchmark Company | Hold |
| 2022-02-04 | Bestätigt | Barclays | Equal Weight |
| 2022-02-04 | Bestätigt | BofA Securities | Neutral |
| 2022-02-04 | Bestätigt | Credit Suisse | Neutral |
| 2022-02-04 | Bestätigt | DA Davidson | Neutral |
| 2022-02-04 | Bestätigt | Evercore ISI | In-line |
| 2022-02-04 | Bestätigt | Piper Sandler | Overweight |
| 2022-02-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-04 | Bestätigt | Robert W. Baird | Outperform |
| 2022-02-04 | Bestätigt | UBS | Neutral |
| 2022-02-04 | Bestätigt | Wedbush | Outperform |
| 2022-02-04 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-01 | Resumed | Stifel | Hold |
| 2022-01-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-01-04 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-01-04 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-12-15 | Bestätigt | JP Morgan | Neutral |
| 2021-12-02 | Herabstufung | UBS | Buy → Neutral |
| 2021-11-01 | Resumed | BofA Securities | Neutral |
| 2021-10-01 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-09-13 | Eingeleitet | Goldman | Neutral |
| 2021-08-30 | Herabstufung | Argus | Buy → Hold |
| 2021-07-30 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-07-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2021-07-30 | Bestätigt | Morgan Stanley | Overweight |
| 2021-07-30 | Bestätigt | Rosenblatt | Neutral |
| 2021-07-30 | Bestätigt | Susquehanna | Neutral |
| 2021-04-06 | Eingeleitet | Evercore ISI | Outperform |
| 2021-03-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-02-08 | Bestätigt | Piper Sandler | Neutral |
| 2021-02-05 | Bestätigt | Pivotal Research Group | Buy |
| 2021-01-21 | Eingeleitet | Piper Sandler | Neutral |
| 2021-01-21 | Eingeleitet | Stifel | Buy |
| 2020-12-17 | Eingeleitet | Cleveland Research | Buy |
| 2020-12-01 | Hochstufung | Argus | Hold → Buy |
| 2020-10-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-29 | Hochstufung | MKM Partners | Neutral → Buy |
| 2020-10-29 | Bestätigt | Pivotal Research Group | Buy |
| 2020-10-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-21 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-28 | Eingeleitet | Guggenheim | Buy |
| 2020-09-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-08-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-03 | Hochstufung | Pivotal Research Group | Hold → Buy |
| 2020-08-03 | Hochstufung | UBS | Neutral → Buy |
| 2020-06-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-05-27 | Herabstufung | Argus | Buy → Hold |
| 2020-05-06 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-05-06 | Bestätigt | Pivotal Research Group | Hold |
| 2020-04-08 | Bestätigt | MKM Partners | Neutral |
| 2020-02-05 | Eingeleitet | Loop Capital | Buy |
| 2020-02-04 | Eingeleitet | Loop Capital | Buy |